DWS CROCI Equity Dividend Fund - Class A (KDHAX)
| Fund Assets | 791.36M |
| Expense Ratio | 1.02% |
| Min. Investment | $1,000 |
| Turnover | 42.00% |
| Dividend (ttm) | 4.83 |
| Dividend Yield | 8.47% |
| Dividend Growth | 56.13% |
| Payout Frequency | Quarterly |
| Ex-Dividend Date | Jun 23, 2025 |
| Previous Close | 53.72 |
| YTD Return | -0.30% |
| 1-Year Return | 7.70% |
| 5-Year Return | 63.32% |
| 52-Week Low | 48.05 |
| 52-Week High | 61.78 |
| Beta (5Y) | n/a |
| Holdings | 42 |
| Inception Date | Mar 18, 1988 |
About KDHAX
DWS CROCI Equity Dividend Fund Class A is an open-end mutual fund designed to provide investors with a high total return by investing primarily in large-cap companies with attractive dividend profiles. The fund utilizes the proprietary CROCI (Cash Return on Capital Invested) methodology, a systematic approach aimed at identifying undervalued companies based on rigorous cash flow analysis. By applying this quantitative process, the fund typically selects a concentrated portfolio of approximately 40 stocks, emphasizing companies that offer strong fundamentals and consistent dividend payments. A distinctive feature of the fund is its flexibility to invest up to 20% of assets in foreign securities, allowing for global diversification while maintaining a focus on developed markets. The portfolio spans various sectors, including information technology, utilities, and industrials, reflecting a diversified allocation across industries. DWS CROCI Equity Dividend Fund Class A plays a notable role in the market by providing investors with a disciplined, valuation-driven approach to dividend investing, targeting companies with sustainable cash flows and robust dividend potential. This focus positions the fund as a strategic choice for those seeking equity income combined with capital appreciation potential.
Performance
KDHAX had a total return of 7.70% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.44%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FVLCX | Fidelity | Fidelity Advisor Value Leaders Fund - Class C | 1.90% |
| FSLVX | Fidelity | Fidelity Stock Selector Large Cap Value Fund | 0.83% |
| SWLVX | Schwab | Schwab ® U.S. Large-Cap Value Index Fund | 0.03% |
| FVLIX | Fidelity | Fidelity Advisor Value Leaders Fund - Class I | 0.90% |
| FSCZX | Fidelity | Fidelity Advisor Stock Selector Large Cap Value Fund - Class Z | 0.72% |
Top 10 Holdings
26.45% of assets| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc. | GILD | 2.75% |
| Altria Group, Inc. | MO | 2.73% |
| Amgen Inc. | AMGN | 2.71% |
| Johnson & Johnson | JNJ | 2.66% |
| Lockheed Martin Corporation | LMT | 2.65% |
| Bristol-Myers Squibb Company | BMY | 2.62% |
| Pfizer Inc. | PFE | 2.62% |
| The J. M. Smucker Company | SJM | 2.57% |
| PepsiCo, Inc. | PEP | 2.57% |
| General Mills, Inc. | GIS | 2.57% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 23, 2025 | $0.3249 | Jun 24, 2025 |
| Mar 24, 2025 | $0.2919 | Mar 25, 2025 |
| Dec 16, 2024 | $3.8082 | Dec 17, 2024 |
| Sep 23, 2024 | $0.403 | Sep 24, 2024 |
| Jun 21, 2024 | $0.3764 | Jun 24, 2024 |
| Mar 21, 2024 | $0.3293 | Mar 22, 2024 |